# HCG Manavata Cancer Centre – FDA Inspection, Sep 27, 2023

Source: https://www.keypedia.com/records/fda_inspections/hcg-manavata-cancer-centre/f8215b21-25f6-415d-bc0d-07953504d70f
Source feed: FDA_Inspections

> FDA inspection 1221683 of HCG Manavata Cancer Centre, September 27, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1221683
- Company Name: HCG Manavata Cancer Centre
- Inspection Date: 2023-09-27
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1179266 - 2022-08-06
- [FDA Inspection 1102925 - 2019-09-27](https://www.keypedia.com/records/fda_inspections/hcg-manavata-cancer-centre/a76202ca-498f-4f7f-8af7-b93d755227ca)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/matthew-c-watson/a1594b84-f65a-42f9-a06d-a68a49eb4b28)

Company: https://www.keypedia.com/companies/hcg-manavata-cancer-centre/b5266eff-a6f7-4c2f-b649-63920b7d709e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c